PROGRAM NAME
ESR Facility Seed Activity
OBJECTIVES
Support new research directions by assisting in gathering of data the will enhance competitiveness for external funding
AWARD
Pilot experiments only; facility user fees waived
CONDITIONS
Investigator supports supply costs
ELIGIBILITY
Students, tenure-track faculty, research scientists
DEADLINE
None
NOTIFICATION OF ACTION
N/A
HOW TO APPLY
Contact ESR Facility
ADDITIONAL INFORMATION
Garry Buettner, 68 EMRB, 5-6749
  
PROGRAM NAME
Residency Research Program
OBJECTIVES
Train otolaryngology residents in medical research
AWARD
Up to $2,500
CONDITIONS
Must be approved by Departmental Research Committee
ELIGIBILITY
Must be Otolaryngology resident
DEADLINE
Plan submitted during R2 year
NOTIFICATION OF ACTION
Approved during R2 year
HOW TO APPLY
Contact person below
ADDITIONAL INFORMATION
Richard Tyler, Chair, Otolaryngology Research Committee, C21-6 GH, 6-2471
  
PROGRAM NAME
Gastroenterology-Hepatology Training Program
OBJECTIVES
Prepare MDs and Ph.D.s for investigation of diseases relevant to the digestive system
AWARD
Salary and limited supply and travel budgets
CONDITIONS
N/A
ELIGIBILITY
Must be permanent U.S. resident who has obtained MD or Ph.D. degree
DEADLINE
Variable
NOTIFICATION OF ACTION
Variable, depending on deadline
HOW TO APPLY
Obtain application materials from contact person below
ADDITIONAL INFORMATION
Joel Weinstock, Internal Medicine, Division of Gastroenterology-Hepatology, 4607 JCP, 6-3792
  
PROGRAM NAME
 Carver Medical Research Initiative Grants
OBJECTIVES
Funding for faculty who have novel research ideas with long-range potential but need to gather preliminary data before submitting an external proposal.
AWARD
Up to $30,000
CONDITIONS
None Specified
ELIGIBILITY
Assistant, Associate or Full Professor in College of Medicine or College of Public Health
DEADLINE
December 1
NOTIFICATION OF ACTION
February 1
HOW TO APPLY
ADDITIONAL INFORMATION
David Bush, CCOM Research Administrator
  
PROGRAM NAME
 Carver Trust Foundation Collaborative Pilot Grants
OBJECTIVES
Seed funding for novel pilot collaborative research to allow PI's to gather preliminary data to submit an external grant.
AWARD
Up to $50,000
CONDITIONS
None Specified
ELIGIBILITY
Assistant, Associate or Full Professor in College of Medicine or College of Public Health
DEADLINE
December 1
NOTIFICATION OF ACTION
February 1
HOW TO APPLY
See guidelines and submit application at the Carver Trust Medical Research Initiatives website. 
ADDITIONAL INFORMATION
David Bush, CCOM Research Administrator
  
PROGRAM NAME
 Holden Comprehensive Cancer Center -- Aiming for A Cure Foundation Grant Opportunity
OBJECTIVES
Supports cancer research with a special interest in, but not limited to, childhood cancers.
AWARD
$100,000 with a maximum of two years to expend all funds.
CONDITIONS
Up to 10% of the budget can be used for faculty salary. The purchase of equipment is discouraged, as are funds for travel.
ELIGIBILITY
Any faculty or staff member at University of Iowa may apply. The research project must be conducted on the UI campus.
DEADLINE
Letter of intent due Noon, April 27, 2018. Full proposal for those selected to move forward due Noon, June 15, 2018.
NOTIFICATION OF ACTION
N/A
HOW TO APPLY
Submit Letter of Intent to Tami Thompson at HCCC (tami-thompson@uiowa.edu). Include as a single PDF: Title page, Summary, and NIH biosketch.
ADDITIONAL INFORMATION
 Contact: Holden Comprehensive Cancer Center Administration, 319-353-8620.  Full guidelines link: https://uihc.org/cancer-research-funding-opportunities
 
PROGRAM NAME
 Holden Comprehensive Cancer Center - Seed Grants - American Cancer Society
OBJECTIVES
For junior faculty members a one-year, cancer-focused research award supported through the Holden Comprehensive Cancer Center's American Cancer Society Institutional Research Grant. The purpose of these seed grant awards is to foster research in cancer that cannot readily be supported through other available sources, and to permit the initiation of promising new projects or novel ideas necessary to obtain the preliminary results for junior faculty to successfully compete for national research grants.
AWARD
Up to $30,000 per award
CONDITIONS
Applicants are not eligible if they have grant support from a national agency, have previously served as P.I. on peer-reviewed grants from a national agency (even if such funding has expired), or if they have received prior support from the American Cancer Society. Recipients must submit a progress report, summarizing the results of the study supported by the ACS-IRG, with information on published papers and grant support as a result of, and separately from, the seed grant support received for the project, and copies of all publications resulting from the work. Annual updates will be required for five years.
ELIGIBILITY
Eligibility is limited to fully affiliated University of Iowa junior faculty (Associates, Assistant Professors, Instructors, or Research Scientists) within six years of their first independent research or faculty appointment. Research must be conducted at the University of Iowa. These awards are intended for junior faculty who are eligible to apply for NIH R01 grants, but who have NOT obtained such a grant. Senior faculty members (higher than Assistant Professor or equivalent), post-doctoral fellows, fellow associates are not eligible to apply. Applicants are NOT eligible if they have received grant support from a national agency, have previously served as P.I. on peer-reviewed grants from a national agency (even if such funding has expired), or if they have received prior support from the ACS. The ACS guidelines stipulate that no awards are to be made to investigators pursing any project funded by the tobacco industry. All applicants are required to verify their eligibility through their Departmental Chair.
DEADLINE
Noon, Monday, August 6, 2018
NOTIFICATION
Notification of awards will be made in August, 2018
HOW TO APPLY
 Guidelines available on Holden website. 
ADDITIONAL INFORMATION
Questions may be directed to Holden Comprehensive Cancer Center Administration, 353-8620. For information on the Holden Comprehensive Cancer Center (HCCC) funding opportunities, please visit https://uihc.org/cancer-research-funding-opportunities. 
  
PROGRAM NAME
 Holden Comprehensive Cancer Center - Vere D. Wenger Travel Award
OBJECTIVES
Vere Wenger funds are avaiable to support partial travel expenses of faculty and staff members in all fields (humanities, law, medicine, natural and social sciences, etc.) from all colleges at the University of Iowa who present papers at conferences and/or who attend professional meetings which contribute to the knowledge of cancer or for the well-being of cancer patients.
AWARD
Awards up to $750 for only one fiscal year, if the applicant has no other grant or departmental funding available.
CONDITIONS
Awards made only in cases where other sources of funding unavailable or inadequate; research must contribute to knowledge of cancer or deal with ways to increase the well-being of cancer patients. Decisions concerning use of funds are made by the leaders of the four formal research programs of the HCCC.  Awards must be applied for and approved before the meeting has occurred.
ELIGIBILITY
All University of Iowa faculty and staff
DEADLINE
Open
NOTIFICATION OF ACTION
Requests are considered upon receipt of application and as funds remain available. 
HOW TO APPLY
Inquries from HCCC members and others should be made to the program leader most appropriate for the research being supported.  Click here for more information. 
1) Letter defining details of dates, location and sponsor of meeting.
2) Letter of acceptance of the paper or a program listing the presentation
3) Brief (2 paragraph) explanation of how the paper relates to cancer or cancer patients
4) Abstract of the paper
5) Endorsement by Leader of Holden Cancer Center Research Program.
ADDITIONAL INFORMATION
Holden Comprehensive Cancer Center Administration, 353-8620. For information on the Holden Comprehensive Cancer Center (HCCC) funding opportunities, please visit https://uihc.org/cancer-research-funding-opportunities. 
  
PROGRAM NAME
OBJECTIVES
The Holden Comprehensive Cancer Center will award one prize of $10,000 from the Donald D. Dorfman Endowment for the best research papers in leukemia and lymphoma published in 2016-2017. 
AWARD
The amount of the award is $10,000. A plaque will be presented to the recipients at a recognition event to be held 11:00-12:00 on Friday, November 17, 2017, with members of the Dorfman family present.
CONDITIONS
Eligible papers are to be published in peer-reviewed journals in 2016-2017, or accepted for publication and currently in press.
ELIGIBILITY
Recipient must be a member of the Holden Comprehensive Cancer Center. Nomination of publications representing major collaborative efforts with other institutions, including those involving colleagues from the Iowa/Mayo Lymphoma SPORE, are encouraged. Authors should have made major contributions to the nominated publications (but do not necessarily need to be first or senior author). Applicants may submit more than one paper, but each paper will be reviewed individually. Recipients of the Dorfman Award from the last cycle are not eligible.
DEADLINE
Deadline for submission: Noon, Friday, October 13, 2017.
NOTIFICATION OF ACTION
Applicants will be notified of the award in November, 2017, with a Recognition Event and presentation of Award Plaque to be held 11:00-12:00 on Friday, November 17, 2017.
HOW TO APPLY
Applicants should submit a single PDF with a copy of the publication and a Cover Letter, which identifies the contact person with name, title, address, telephone number, the full reference, a brief summary describing why you feel the paper is deserving of the award.  The summary should include the key issues addressed in the manuscript, a description of the impact of your paper on these issues and the role the applying investigator played on the paper. Failure to provide the summary and identifying key issues will negatively impact on the review of the manuscript. Please forward a single PDF document to: Tami Thompson.
ADDITIONAL INFORMATION
Holden Comprehensive Cancer Center Administration, 353-8620. For information on the Holden Comprehensive Cancer Center (HCCC) funding opportunities, please visit https://uihc.org/cancer-research-funding-opportunities. 
  
PROGRAM NAME
Institutional Research Fellowship for Kidney Disease, Hypertension, and Cell Biology
OBJECTIVES
To support postdoctoral fellows or potential postdoctoral fellows whose research projects relate to one or more of these areas: kidney disease, hypertension, cell biology.
AWARD
None Specified
CONDITIONS
None Specified
ELIGIBILITY
Applicants must be a U.S. citizen or Green Card holder, have received an M.D. or Ph.D. degree (or equivalent), and may not have received more than three years of support from a National Research Service Award.
DEADLINE
 None Specified
NOTIFICATION OF ACTION
None Specified
HOW TO APPLY
Candidates interested in applying for this award are invited to inquire at the Nephrology Division office (356-3446).
ADDITIONAL INFORMATION
  
PROGRAM NAME
 Holden Comprehensive Cancer Center - SPORE Career Enhancement Program (CEP)
OBJECTIVES
The Holden Comprehensive Cancer Center, in conjunction with the Mayo Clinic, holds a National Cancer Institute Specialized Program of Research Excellence (SPORE) grant for lymphoma research. Associated with this grant is a Career Enhancement Program, aimed toward basic scientists who are interested in developing a translational research focus or clinicians wishing to acquire the laboratory skills required to become translational researchers in lymphoma.
AWARD
A maximum of $25,000 per year in direct costs will be provided through the Iowa/Mayo SPORE grant with $25,000 provided in matching institutional support from each institution for a total award of $50,000.  The exact amount of the award is contingent on NIH funding.
CONDITIONS
None Specified
ELIGIBILITY
Two types of individuals targeted are:
-- Laboratory investigators at the senior post-doctoral or junior faculty level (Assistant Professor or Research Scientist) who have demonstrated outstanding research potential and have an interest in a career in translational lymphoma research, but are not yet independently funded to perform this research. More experienced successful investigators with an interest in shifting their focus towards translational lymphoma research, are also eligible.
-- Clinicians who have demonstrated interest and ability in translational research during their clinical fellowship training, are committed to careers in translational research, and wish to devote the first two years of their faculty careers to additional research training in pursuit of this career.
DEADLINE
The deadline for the Letter of Concept is Noon (Central Time), Monday, April 16, 2018.
(Inivited only) The deadline for the Invited Full Proposal is Noon (Central Time), Friday, May 18, 2018.
NOTIFICATION OF ACTION
 June 2018
HOW TO APPLY
ADDITIONAL INFORMATION
Questions may be directed to Holden Comprehensive Cancer Center Administration, 353-8620. <pre information is available on the Holden Comprehensive Cancer Center (HCCC) Research Funding website.  
  
PROGRAM NAME
 Holden Comprehensive Cancer Center - SPORE Developmental Research Projects
OBJECTIVES
The University of Iowa / Mayo Clinic Lymphoma Specialized Program of Research Excellence (UI/MC Lymphoma SPORE) is a center grant funded through the National Cancer Institute. The mission of the UI/MC Lymphoma SPORE developmental research programs is to encourage innovative laboratory and clinical studies in lymphoma research, and to provide funds to support previously untested hypotheses or other innovative research objectives that address problems in lymphoma.  The project duration is one year.
AWARD
A maximum of $25,000 per year will be provided through the SPORE grant with $25,000 provided in Institutional support from each institution for a total award of $50,000. No overhead expenses will be paid to the applicant organization and the purchase of equipment is not allowed. All budgetary requests must be justified.
CONDITIONS
Should the investigator discontinue the project, or leave the designated institution, the UI/MC Lymphoma SPORE must be notified two months in advance of these changes. Failure to comply with this policy may jeopardize any future awards to the institution(s). The investigator may apply for transfer of the grant. If the transfer is not approved, unexpended portions of the grant must be returned to the UI/MC Lymphoma SPORE within sixty days.
ELIGIBILITY
Investigators planning to conduct their research in universities, hospitals, research institutions, and federal agencies are eligible to apply. Applicants must hold either a Ph.D. or M.D. degree or equivalent.
DEADLINE
The deadline for the Letter of Concept is Noon (Central Time), Monday, April 16, 2018.  
(Invited only) The deadline for the Invited Full Proposal is Noon (Central Time), Friday, May 18, 2018.
NOTIFICATION OF ACTION
June 2018
HOW TO APPLY

Download the SPORE Developmental guidelines 
ADDITIONAL INFORMATION
Questions may be directed to Holden Comprehensive Cancer Center Administration, 353-8620. More information is available on the Holden Comprehensive Cancer Center (HCCC) Research Funding website. 
  
PROGRAM NAME
OBJECTIVES
Diana Benz Seed Grant Opportunity for Support of cancer research seed grant geared towards psychosocial issues, complementary and alternative medicine, and other aspects of cancer research with a focus on quality of life for cancer patients and survivors.
AWARD
Up to $20,000 per award
CONDITIONS
The principal investigator must have a full-time affiliation with the University of Iowa and should intend to carry out the research project on campus.
ELIGIBILITY
Any faculty or staff member at the University of Iowa is eligible.
DEADLINE
Noon, Monday, November 21, 2016
NOTIFICATION OF ACTION
Notification of awards will be made in December 2016.
HOW TO APPLY
Contact Cancer Center Administration, 5970Z JPP, 353-8620 or download the guidelines.
ADDITIONAL INFORMATION
Holden Comprehensive Cancer Center Administration, 353-8620. For information on the Holden Comprehensive Cancer Center (HCCC) funding opportunities, please visit https://uihc.org/cancer-research-funding-opportunities. 
  
PROGRAM NAME NET SPORE Career Enhancement Program (CEP) Letter of Concept (LOC)
OBJECTIVES The University of Iowa Neuroendocrine Tumors Specialized Program of Research Excellence (NET SPORE) is a center grant funded through the National Cancer Institute. The NET SPORE Career Enhancement Program (CEP) is aimed at developing basic scientists develop translational research skills and to clinicians acquire laboratory skills to become translational researchers in neuroendocrine tumors.
AWARD $100,000 for one Career Enhancement Program (CEP) award.
CONDITIONS See complete announcement on website. Budget period September 1, 2018 to August 31, 2019.
ELIGIBILITY See Guideline sheet for eligibility.
DEADLINE Letter of Concept (LOC) due July 5, 2018. For selected LOC only - full proposal deadline is August 10, 2018.
NOTIFICATION Selected LOC notification before July 13, 2018. Full Proposal due August 10, 2018. Final award notice before September 1, 2018.
HOW TO APPLY Guidelines available on Holden website
ADDITIONAL INFORMATION Questions may be directed to Karla Stout at karla-stout@uiowa.edu or the Program Director listed in each Guideline. For information  about the Holden Comprehensive Cancer Center (HCCC) research, please click here. 
  
PROGRAM NAME NET SPORE Developmental Research Program (DRP) Letter of Concept (LOC)
OBJECTIVES The University of Iowa Neuroendocrine Tumors Specialized Program of Research Excellence (NET SPORE) is a center grant funded through the National Cancer Institute. The purpose of the NET SPORE Developmental Research Program (DRP) is to encourage innovative laboratory and clinical studies in neuroendocrine tumor research, and to provide funds to support previously untested hypotheses or other innovative research objectives that address problems in neuroendocrine cancer
AWARD $50,000 for each of two Developmental Research Program (DRP) awards.
CONDITIONS See complete announcement on website. Budget period September 1, 2018 to August 31, 2019.
ELIGIBILITY See Guideline sheet for eligibility.
DEADLINE Letter of Concept (LOC) due July 5, 2018. For selected LOC only - full proposal deadline is August 10, 2018.
NOTIFICATION Selected LOC notification before July 13, 2018. Full Proposal due August 10, 2018. Final award notice before September 1, 2018.
HOW TO APPLY Guidelines available on Holden website.
ADDITIONAL INFORMATION Questions may be directed to Karla Stout at karla-stout@uiowa.edu or the Program Director listed in each Guideline. For information  about the Holden Comprehensive Cancer Center (HCCC) research, please click here.

^ Return to top ^